Julie Hambleton Spring Works Therapeutics, Inc. (SWTX) insider trading activity
Julie Hambleton is Director of SpringWorks Therapeutics, Inc.. Currently has a direct ownership of 4,095 shares of SWTX, which is worth approximately $135,503. The most recent transaction as insider was on Jun 03, 2024, when has been sold 4,648 shares (Common Stock) at a price of $40.89 per share, resulting in proceeds of $190,056. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
4.1K
0%
3M change
11.9%
12M change
Total Value Held
$135,503
Julie Hambleton Transaction History
Also insider at
JH
Julie Hambleton
Director
Stamford,, CT